Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Dk, Hoganson"'
Autor:
Dl, Gu, Am, Gonzalez, Ma, Printz, Doukas J, Ying W, D'Andrea M, Dk, Hoganson, Dt, Curiel, Jt, Douglas, Ba, Sosnowski, Andrew Baird, Sl, Aukerman, Gf, Pierce
Publikováno v:
Europe PubMed Central
Adenovirus (Ad) have been used as vectors to deliver genes to a wide variety of tissues. Despite achieving high expression levels in vivo, Ad vectors display normal tissue toxicity, transient expression, and antivector immune responses that limit the
Publikováno v:
Europe PubMed Central
Transduction of malignant cells with toxin genes provides a novel means to promote tumor cell destruction. The efficacy of a toxin gene is dependent on the cell type targeted, the quantity of exogenous protein synthesized, and the mechanisms of growt
Autor:
Doukas J; Selective Genetics, San Diego, CA 92121, USA. jdoukas@selectivegenetics.com, Chandler LA, Gonzalez AM, Gu D, Hoganson DK, Ma C, Nguyen T, Printz MA, Nesbit M, Herlyn M, Crombleholme TM, Aukerman SL, Sosnowski BA, Pierce GF
Publikováno v:
Human gene therapy [Hum Gene Ther] 2001 May 01; Vol. 12 (7), pp. 783-98.
Autor:
Hoganson DK; Selective Genetics, Inc., 11035 Roselle Street, San Diego, California 92121, USA. hoganson@selectivegenetics.com, Sosnowski BA, Pierce GF, Doukas J
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2001 Jan; Vol. 3 (1), pp. 105-12.
Autor:
Chandler LA; Selective Genetics, Incorporated, San Diego, California 92121, USA. loisc@selectivegenetics.com, Doukas J, Gonzalez AM, Hoganson DK, Gu DL, Ma C, Nesbit M, Crombleholme TM, Herlyn M, Sosnowski BA, Pierce GF
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2000 Aug; Vol. 2 (2), pp. 153-60.
Autor:
Hoganson DK; Department of Basic Pharmaceutical Sciences, University of South Carolina, Columbia 29208, USA., Williams AW, Berger SH
Publikováno v:
Biochemical pharmacology [Biochem Pharmacol] 1999 Nov 15; Vol. 58 (10), pp. 1529-37.
Autor:
Doukas J; Amgen, Inc., Thousand Oaks, California 91320, USA. jdoukas@selectivegenetics.com, Hoganson DK, Ong M, Ying W, Lacey DL, Baird A, Pierce GF, Sosnowski BA
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 1999 Aug; Vol. 13 (11), pp. 1459-66.
Autor:
Gu DL; Selective Genetics, Inc., San Diego, California 92121, USA. dlgu@selectivegenetics.com, Gonzalez AM, Printz MA, Doukas J, Ying W, D'Andrea M, Hoganson DK, Curiel DT, Douglas JT, Sosnowski BA, Baird A, Aukerman SL, Pierce GF
Publikováno v:
Cancer research [Cancer Res] 1999 Jun 01; Vol. 59 (11), pp. 2608-14.
Autor:
Hoganson DK; Selective Genetics, Inc., San Diego, CA 92121, USA., Chandler LA, Fleurbaaij GA, Ying W, Black ME, Doukas J, Pierce GF, Baird A, Sosnowski BA
Publikováno v:
Human gene therapy [Hum Gene Ther] 1998 Nov 20; Vol. 9 (17), pp. 2565-75.
Autor:
Hoganson DK; Department of Medicine, University of North Carolina at Chapel Hill, 27599, USA., Matsui H, Batra RK, Boucher RC
Publikováno v:
Human gene therapy [Hum Gene Ther] 1998 May 20; Vol. 9 (8), pp. 1143-56.